A carregar...
Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells
Incretin-based therapy such as GLP-1 receptor agonists and DPP-4 inhibitors for type 2 diabetes mellitus is characterized by glucose-dependent insulin secretion and glucose-inhibited glucagon secretion. Recently, autophagy deficiency in islet β cells has been shown to contribute to the pathogenesis...
Na minha lista:
| Publicado no: | Islets |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878271/ https://ncbi.nlm.nih.gov/pubmed/26744903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19382014.2015.1129096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|